Tecan’s Phase Separator™: advancing automation for liquid biopsy and biobanking

FHS
July 21, 2023
10:56 am

Tecan proudly unveils Phase Separator™, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics,
proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders.

Pharmalittle: Novo Nordisk to spend $6 billion to boost production; FDA okays world’s first vaccine for chikungunya

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

November 10, 2023

Brett Favre’s Parkinson’s: ‘Hell, I Wrote the Book on Head Trauma’

Several news items this week put professional football and head trauma back in the spotlight. On Monday, a study showed that one-third of former National

September 28, 2024

Metabolic syndrome linked to higher pancreatic cancer risk, study shows

Study finds a significant association between metabolic syndrome and an increased risk of pancreatic cancer, highlighting the importance of MetS prevention and management.

December 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.